Want to join the conversation?
For 1Q17, $INTU expects revenue to be $740-760MM, GAAP operating loss to be $65-75MM, GAAP loss per share to be $0.19-0.21 and non-GAAP diluted EPS to be $0.01-0.03. For FY17, revenue is expected to be between $5.0-5.1Bil, GAAP operating income of $1.33-1.38Bil, GAAP diluted EPS of $3.35-3.45 & non-GAAP diluted EPS of $4.30-4.40.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)